Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
NATCO is the first company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole
First and only biologic approved in the EU in patients with severe asthma with no phenotype or biomarker limitations
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Apollo Pharmacy has over 50% market share amongst India’s organized pharmacies
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
The #pledgemyeyes initiative reached out to over 30 million people across the country and the website registered 3X more pledges compared to the present numbers
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
These moves are designed to strengthen the company’s medical and scientific focus and support its continued record growth through closer alignment of all aspects of strategy, sales, and delivery to delight customers
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
Subscribe To Our Newsletter & Stay Updated
